(Q91853647)
Statements
Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)? (English)
Hunter B Moore
Christopher D Barrett
Ernest E Moore
Robert C McIntyre
Peter K Moore
Daniel S Talmor
Frederick A Moore
Michael B Yaffe